tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Abivax price target raised, named a ‘Best Idea’ at Guggenheim
PremiumThe FlyAbivax price target raised, named a ‘Best Idea’ at Guggenheim
1M ago
Abivax price target raised to $120 from $112 at BTIG
Premium
The Fly
Abivax price target raised to $120 from $112 at BTIG
1M ago
Abivax’s Obefazimod: Promising Clinical Results and Market Potential Drive Buy Rating
Premium
Ratings
Abivax’s Obefazimod: Promising Clinical Results and Market Potential Drive Buy Rating
1M ago
Abivax price target raised to $101 from $71 at Morgan Stanley
PremiumThe FlyAbivax price target raised to $101 from $71 at Morgan Stanley
2M ago
Promising Outlook for Abivax SA: Buy Rating Supported by Strong Clinical Results and Financial Position
Premium
Ratings
Promising Outlook for Abivax SA: Buy Rating Supported by Strong Clinical Results and Financial Position
2M ago
0RA9 Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
0RA9 Upcoming Earnings Report: What to Expect?
2M ago
Abivax announces trading resumption of shares on Euronext Paris
PremiumThe FlyAbivax announces trading resumption of shares on Euronext Paris
4M ago
Abivax $400M Spot Secondary; price range $62.50-$65.00
Premium
The Fly
Abivax $400M Spot Secondary; price range $62.50-$65.00
4M ago
Abivax announces $400M ADS offering
Premium
The Fly
Abivax announces $400M ADS offering
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100